• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    GigCapital 5 Inc. filed SEC Form 8-K: Regulation FD Disclosure

    2/22/24 9:00:31 AM ET
    $GIA
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $GIA alert in real time by email
    8-K
    false 0001844505 0001844505 2024-02-15 2024-02-15

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    February 15, 2024

    Date of Report (date of earliest event reported)

     

     

    GIGCAPITAL5, INC.

    (Exact name of Registrant as specified in its charter)

     

     

     

    Delaware   001-40389   86-1728920

    (State or other jurisdiction of

    incorporation or organization)

     

    (Commission

    File Number)

     

    (I.R.S. Employer

    Identification Number)

    1731 Embarcadero Rd., Suite 200

    Palo Alto, CA 94303

    (Address of principal executive offices)

    (650) 276-7040

    (Registrant’s telephone number, including area code)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☒

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading
    Symbols

     

    Name of each exchange

    on which registered

    Common Stock, par value $0.0001 per share   GIA   New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☒

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     


    Item 2.03

    Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of Registrant.

    As previously disclosed, on December 13, 2023, GigCapital5, Inc. (the “Company”) issued an additional unsecured non-convertible promissory note to GigAcquisitions5, LLC, a Delaware limited liability company (the “Sponsor”), as amended on February 7, 2024 (the “Second Non-Convertible Working Capital Note”) for a collective principal amount of $262,246.92.

    On February 15, 2024, the Company amended and restated the Second Non-Convertible Working Capital Note (the “Third Non-Convertible Working Capital Note”) to reflect an additional principal amount of $35,000 extended by the Sponsor to the Company for a collective principal amount under the Third Non-Convertible Working Capital Note of $297,246.92. The Third Non-Convertible Working Capital Note was issued to provide the Company with additional working capital and will not be deposited into the Trust Account. The Company issued the Third Non-Convertible Working Capital Note in consideration for an additional loan from the Sponsor to fund the Company’s working capital requirements.

    The Third Non-Convertible Working Capital Note bears no interest and is repayable in full upon the consummation of a business combination by the Company.

    A copy of the Third Non-Convertible Working Capital Note is attached as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.

     

    Item 5.07

    Submission of Matters to a Vote of Security Holders

    At the Annual Meeting, of the 8,657,593 shares of common stock outstanding and entitled to vote, 8,136,762 shares were represented, constituting a quorum. The final results for the matter submitted to a vote of stockholders at the Annual Meeting are as follows:

    Proposal 1: The stockholders approved and adopted the Business Combination Agreement, dated as of December 8, 2022, as amended (the “Business Combination Agreement”), by and among the Company, QT Imaging, Inc. (“QT Imaging”), and QTI Merger Sub, Inc. (“Merger Sub”), and approved the transactions contemplated thereby (together, the “Business Combination”), including the merger of Merger Sub with and into QT Imaging, with QT Imaging surviving the merger, and the issuance of common stock of the Company to QT Imaging equity holders as merger consideration, by the votes set forth in the table below:

     

    For

     

    Against

     

    Abstained

    8,136,762   0   0

    Proposal 2: The stockholders voted in favor of considering and voting upon a proposal to amend the Company’s current amended and restated certificate of incorporation (“Charter”) to provide for the classification of its Board into three classes of directors with staggered three-year terms of office and to make certain related changes:

     

    For

     

    Against

     

    Abstained

    8,136,762   0   0

    Proposals 3A and 3B: The stockholders voted in favor of authorizing an additional share capital to the aggregate of 510,000,000 shares, consisting of 500,000,000 shares of common stock, and 10,000,000 shares of preferred stock, and amending the Company’s Charter to provide for certain additional changes, including but not limited to, changing the Company’s name from “GigCapital5, Inc.” to “QT Imaging Holdings, Inc.” and eliminating certain provisions specific to GigCapital5’s status as a blank check company:

     

    For

     

    Against

     

    Abstained

    8,136,762   0   0

     


    Proposal 4: The stockholders approved the election, effective upon the closing of the Business Combination (the “Closing”), of seven directors to serve staggered terms on the Board until the 2025, 2026 and 2027 annual meetings of stockholders, respectively, and until their respective successors are duly elected and qualified:

     

    For

     

    Against

     

    Abstained

    8,136,762   0   0

    Proposal 5: The stockholders approved, for purposes of complying with applicable listing rules of the Nasdaq Global Market, (i) the issuance of more than 20% of the Company’s outstanding common stock in connection with the Business Combination, including up to 14,778,170 shares of common stock to the QT Imaging equity holders; and (ii) the issuance of an aggregate of up to $50,000,000 of common stock of QT Imaging Holdings, Inc. from time to time to Yorkville over a 36-month period following the Closing pursuant to the Yorkville Financing:

     

    For

     

    Against

     

    Abstained

    8,136,762   0   0

    Proposal 6: The stockholders approved the QT Imaging Holdings, Inc. 2024 Equity Incentive Plan (the “Incentive Plan”), including the authorization of the initial share reserve under such Incentive Plan:

     

    For

     

    Against

     

    Abstained

    8,013,048   123,714   0

    No other items were presented for stockholder approval at the Annual Meeting.

     

    Item 7.01

    Regulation FD Disclosure.

    The information set forth below under this Item 7.01 is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

    On February 22, 2024, the Company issued a press release announcing the results of the Annual Meeting. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference.

     

    Item 9.01

    Financial Statements and Exhibits

     

    Exhibit

    Number

        
    10.01    Third Non-Convertible Working Capital Note dated February 15, 2024
    99.1    Press Release, dated February 22, 2024
    104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

     


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Dated: February 22, 2024

     

    By:  

    /s/ Dr. Raluca Dinu

    Name:   Dr. Raluca Dinu
    Title:   Chief Executive Officer, President, Secretary, and Director
    Get the next $GIA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GIA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GIA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Budagov Stas

      3 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

      3/8/24 7:36:16 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 3 filed by new insider Weiner Zeev

      3 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

      3/8/24 7:18:19 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 3 filed by new insider Dickson Daniel

      3 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

      3/8/24 7:17:06 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $GIA
    Leadership Updates

    Live Leadership Updates

    See more
    • Catalyze Partners Appoints Raanan Horowitz to Board of Advisors

      Catalyze Partners has appointed Raanan Horowitz, former CEO of Elbit Systems of America, to its Board of Advisors. With over 30 years of leadership experience across the defense, commercial aviation, and healthcare sectors, Horowitz has a proven track record of driving growth and overseeing strategic acquisitions. Drawing from his extensive experience in scaling companies and navigating complex markets, Horowitz will help Catalyze further develop its portfolio of innovative technology-driven companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241203110969/en/Catalyze Partners adds Raanan Horowitz to its Board of Advisors.

      12/3/24 10:00:00 AM ET
      $BBAI
      $GIA
      Computer Software: Prepackaged Software
      Technology
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $GIA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $GIA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SEC Form SC 13D filed by GigCapital 5 Inc.

      SC 13D - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)

      3/18/24 8:33:56 AM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13D filed by GigCapital 5 Inc.

      SC 13D - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)

      3/18/24 8:30:25 AM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G/A filed by GigCapital 5 Inc. (Amendment)

      SC 13G/A - GigCapital5, Inc. (0001844505) (Subject)

      2/22/24 8:39:14 AM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Catalyze Partners Appoints Raanan Horowitz to Board of Advisors

      Catalyze Partners has appointed Raanan Horowitz, former CEO of Elbit Systems of America, to its Board of Advisors. With over 30 years of leadership experience across the defense, commercial aviation, and healthcare sectors, Horowitz has a proven track record of driving growth and overseeing strategic acquisitions. Drawing from his extensive experience in scaling companies and navigating complex markets, Horowitz will help Catalyze further develop its portfolio of innovative technology-driven companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241203110969/en/Catalyze Partners adds Raanan Horowitz to its Board of Advisors.

      12/3/24 10:00:00 AM ET
      $BBAI
      $GIA
      Computer Software: Prepackaged Software
      Technology
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • GigCapital5, Inc. Announces Closing Date for Business Combination With QT Imaging

      QT Imaging Holdings, Inc. Expected to Begin Trading on Nasdaq Under Ticker Symbols "QTI" on March 5, 2024 GigCapital5, Inc. (("GigCapital5", NASDAQ:GIA), a Private-to-Public Equity (PPE)™ entity also known as special purpose acquisition company ("SPAC"), today announced that the completion of their previously announced business combination (the "Business Combination") with QT Imaging, Inc. ("QT Imaging"), a technology company engaged in an innovative automated breast imaging system producing high-resolution transmission ultrasound images, will take place on March 4, 2024. The Business Combination was approved at an Annual Meeting of GigCapital5's stockholders on February 20, 2024. Upon co

      2/29/24 4:45:00 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • GigCapital5, Inc. Announces Shareholder Approval of Business Combination

      GigCapital5, Inc. ("GigCapital5") (NASDAQ:GIA) today announced that at the Annual Meeting of GigCapital5's stockholders (the "Annual Meeting") held on February 20, 2024, GigCapital5's stockholders voted to approve the previously announced proposed business combination between GigCapital5, QT Imaging, Inc. ("QT Imaging") and QTI Merger Sub, Inc. ("Merger Sub"), as well as all other proposals related to the Business Combination. GigCapital5 plans to file the results of the Annual Meeting, as tabulated by an independent inspector of elections, on Form 8-K with the Securities and Exchange Commission today. About GigCapital5 On December 8, 2022, GigCapital5 entered into a Business Combinat

      2/22/24 9:00:00 AM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $GIA
    SEC Filings

    See more
    • SEC Form 8-K filed by GigCapital 5 Inc.

      8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

      3/18/24 5:00:32 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • GigCapital 5 Inc. filed SEC Form 8-K: Other Events

      8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

      3/15/24 9:01:02 AM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • GigCapital 5 Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

      8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

      3/8/24 5:04:04 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care